Management of painful diabetic neuropathy: guideline guidance or jungle?

Abstract:

:The treatment of painful diabetic polyneuropathy (PDPN) remains a major challenge. A number of reasons have made the guidelines on PDPN management of particular interest, including its high prevalence, health and socioeconomic impact, interdisciplinary nature and the need for updated evidence-based information to refine patient-tailored treatment by weighing up the risks of each treatment against its proven benefits, as well as optimizing the use of all available resources. The various guidelines on the management of neuropathic pain developed so far contain some differences in their work methodology and results. Some variations in the recommendations are to be expected but could be disorienting and confusing for stakeholders. In this review, a critical evaluation of the more recent guidelines on the management of PDPN is provided together with highlights on points of agreement and disagreement as well as insights into their clinical aspects.

journal_name

Curr Diab Rep

journal_title

Current diabetes reports

authors

Spallone V

doi

10.1007/s11892-012-0287-2

subject

Has Abstract

pub_date

2012-08-01 00:00:00

pages

403-13

issue

4

eissn

1534-4827

issn

1539-0829

journal_volume

12

pub_type

杂志文章,评审
  • Diabetic foot disease in people with advanced nephropathy and those on renal dialysis.

    abstract::Among the spectrum of risk for diabetic foot disease conferred by chronic kidney disease (CKD), end-stage renal disease (ESRD) has emerged as a novel independent risk factor. Apart from the classical triad of neuropathy, infection, and peripheral arterial disease that operate in these individuals, the risk is further ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-010-0128-0

    authors: Ndip A,Lavery LA,Boulton AJ

    更新日期:2010-08-01 00:00:00

  • Integrated Cardio-Respiratory Control: Insight in Diabetes.

    abstract::Autonomic dysfunction is a frequent and relevant complication of diabetes mellitus, as it is associated with increased morbidity and mortality. In addition, it is today considered as predictive of the most severe diabetic complications, like nephropathy and retinopathy. The classical methods of screening are the cardi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0804-9

    authors: Bernardi L,Bianchi L

    更新日期:2016-11-01 00:00:00

  • Diagnosis, screening, and management of cystic fibrosis-related diabetes.

    abstract::Diabetes is a common complication of cystic fibrosis (CF), occurring in approximately 40% of adult patients. It is clinically distinct from type 1 or type 2 diabetes, and requires a unique approach. Because of evidence that it is associated with increased morbidity and mortality, prompt diagnosis and aggressive manage...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-002-0069-3

    authors: Moran A

    更新日期:2002-04-01 00:00:00

  • Bioprinting an Artificial Pancreas for Type 1 Diabetes.

    abstract:PURPOSE OF REVIEW:Pancreatic islet cell transplantation is currently the only curative cell therapy for type 1 diabetes mellitus. However, its potential to treat many more patients is limited by several challenges. The emergence of 3D bioprinting technology from recent advances in 3D printing, biomaterials, and cell bi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1166-x

    authors: Kim J,Kang K,Drogemuller CJ,Wallace GG,Coates PT

    更新日期:2019-07-04 00:00:00

  • Low-carbohydrate diets: an update on current research.

    abstract::The diabetes and obesity epidemics have stimulated research to assess the benefits and potential risks of low-carbohydrate diets. Carbohydrate comprises less than 45% of calories in carbohydrate-restricted diets, but very low carbohydrate ketogenic diets may restrict carbohydrate to 20 g initially with variability in ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0061-2

    authors: Wylie-Rosett J,Davis NJ

    更新日期:2009-10-01 00:00:00

  • The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery.

    abstract::Bariatric surgery has emerged as the most durably effective treatment of type 2 diabetes (DM). However, the mechanisms governing improvement in glucose homeostasis have yet to be fully elucidated. In this review we discuss the various types of surgical interventions and the multitude of factors that potentially mediat...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0481-5

    authors: Nguyen KT,Korner J

    更新日期:2014-01-01 00:00:00

  • Heterogeneity in Obesity: Genetic Basis and Metabolic Consequences.

    abstract:PURPOSE OF REVIEW:Our review provides a brief summary of the most recent advances towards the identification of the genetic basis of specific aspects of obesity and the quantification of their consequences on health. We also highlight the most promising avenues to be explored in the future. RECENT FINDINGS:While obesi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-1285-4

    authors: Sulc J,Winkler TW,Heid IM,Kutalik Z

    更新日期:2020-01-22 00:00:00

  • Oral Agents for the Treatment of Gestational Diabetes.

    abstract:PURPOSE OF REVIEW:To review the current evidence of the safety and efficacy of the use of oral agents for treatment of gestational diabetes (GDM). RECENT FINDINGS:The use of metformin and glyburide in pregnancy for treatment of GDM has dramatically increased since the early 2000s. Meta-analyses suggest that glyburide ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1093-2

    authors: Finneran MM,Landon MB

    更新日期:2018-09-28 00:00:00

  • Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes.

    abstract::Patients with type 1 diabetes (T1D) suffer excess mortality from cardiovascular disease (CVD) that has persisted despite substantial reductions in microvascular complications. Although T1D and type 2 diabetes (T2D) are etiologically distinct, it has generally been assumed that CVD in T1D is "the same disease" as that ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0598-1

    authors: Lipes MA,Galderisi A

    更新日期:2015-05-01 00:00:00

  • Genetics of diabetes complications.

    abstract::A large body of evidence indicates that the risk for developing chronic diabetic complications is under the control of genetic factors. Previous studies using a candidate gene approach have uncovered a number of genetic loci that may shape this risk, such as the VEGF gene for retinopathy, the ELMO1 gene for nephropath...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-010-0147-x

    authors: Doria A

    更新日期:2010-12-01 00:00:00

  • Bariatric Surgery for Monogenic Non-syndromic and Syndromic Obesity Disorders.

    abstract:PURPOSE OF REVIEW:The global prevalence of obesity has increased rapidly over the last decades, posing a severe threat to human health. Currently, bariatric surgery is the most effective therapy for patients with morbid obesity. It is unknown whether this treatment is also suitable for patients with obesity due to a co...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01327-7

    authors: Vos N,Oussaada SM,Cooiman MI,Kleinendorst L,Ter Horst KW,Hazebroek EJ,Romijn JA,Serlie MJ,Mannens MMAM,van Haelst MM

    更新日期:2020-07-30 00:00:00

  • The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.

    abstract::As the incidence of diabetes mellitus continues to rise, parallel increases in the rates of diabetic atherosclerotic vascular disease are projected to impart major health and socioeconomic challenges for authorities worldwide. Diabetes results in a proatherogenic phenotype, manifesting in an accelerated, diffuse, poly...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0270-y

    authors: Puri R,Kataoka Y,Uno K,Nicholls SJ

    更新日期:2012-06-01 00:00:00

  • Diabetes in Montana's Indians: the epidemiology of diabetes in the Indians of the Northern Plains and Canada.

    abstract::The prevalence of diabetes is two- to threefold higher in American Indians in Montana compared with the non-Indian population. High rates of diabetes have also been described in Canadian aboriginal populations closely related to the tribes in Montana. Diabetes in pregnancy has increased among Indian mothers and high-b...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-004-0028-2

    authors: Gohdes D,Oser CS,Harwell TS,Moore KR,McDowall JM,Helgerson SD

    更新日期:2004-06-01 00:00:00

  • The role of complementary and alternative medicine in diabetes.

    abstract::Complementary and alternative medicine (CAM) describes a diverse group of medical and health care systems, practices, and products not currently considered to be part of conventional medicine. Inadequacies in current treatments for diabetes have led 2 to 3.6 million Americans to use CAM for diabetes treatment, despite...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-006-0042-7

    authors: Dham S,Shah V,Hirsch S,Banerji MA

    更新日期:2006-06-01 00:00:00

  • Endothelial dysfunction in human diabetes.

    abstract::In nondiabetic individuals, a poor response to an endothelium-dependent vasodilator in coronary vessels has been shown to increase the likelihood of a future cardiovascular event. Such prospective data are not as yet available in patients with type 1 or type 2 diabetes. However, consistent with the greatly increased c...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-002-0054-x

    authors: Mäkimattila S,Yki-Järvinen H

    更新日期:2002-02-01 00:00:00

  • MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.

    abstract::Recent estimates suggest that 1 in 12 of the global population suffers from diabetes mellitus. Approximately 40 % of those affected will go on to develop diabetes-related chronic kidney disease or diabetic nephropathy (DN). DN is a major cause of disability and premature death. Existing tests for prognostic purposes a...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0724-8

    authors: Simpson K,Wonnacott A,Fraser DJ,Bowen T

    更新日期:2016-03-01 00:00:00

  • Inflammation and diabetic nephropathy.

    abstract::Diabetic nephropathy has become the main cause of renal failure, but unfortunately the intimate mechanisms leading to the development and progression of renal injury are not yet fully known. Activated innate immunity and inflammation are relevant factors in the pathogenesis of diabetes. Moreover, different inflammator...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-006-0080-1

    authors: Mora C,Navarro JF

    更新日期:2006-12-01 00:00:00

  • Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy.

    abstract::Diabetic nephropathy is continuing to rise in incidence, despite awareness of tight glycemic control and blood pressure. The identification that matrix accumulation is driven by transforming growth factor-beta (TGF-beta) has led to a concerted effort to apply antifibrotic strategies for this disorder. Recent studies h...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-004-0055-z

    authors: McGowan TA,Zhu Y,Sharma K

    更新日期:2004-12-01 00:00:00

  • FTO and obesity: mechanisms of association.

    abstract::The Fat mass and obesity associated (FTO) gene is a newly identified genetic factor for obesity. However, the exact molecular mechanisms responsible for the effect of FTO on obesity remain largely unknown. Recent studies from genome-wide associated studies reveal that genetic variants in the FTO gene are associated no...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0486-0

    authors: Zhao X,Yang Y,Sun BF,Zhao YL,Yang YG

    更新日期:2014-01-01 00:00:00

  • Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus.

    abstract:PURPOSE OF REVIEW:This review aims to discuss the burden of type 2 diabetes in youth and summarize the studies that have utilized noninvasive techniques to assess early vascular disease in youth with type 2 diabetes. RECENT FINDINGS:Noninvasive imaging modalities provide researchers with tools to investigate the vascu...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-017-0869-0

    authors: Shah AS,Urbina EM

    更新日期:2017-06-01 00:00:00

  • Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutrition.

    abstract::Among the factors predisposing to type 2 diabetes in children, adolescents, and young adults, the health and behavior of both the mother and father are critical. Prevention and treatment of parental nutritional disorders (including obesity and malnutrition), promotion of breastfeeding, and avoidance of overfeeding of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-011-0246-3

    authors: Bartz S,Freemark M

    更新日期:2012-02-01 00:00:00

  • A review of adolescent adherence in type 1 diabetes and the untapped potential of diabetes providers to improve outcomes.

    abstract::Only 21 % of adolescents with type 1 diabetes (T1D) meet glycemic goals set forth by the American Diabetes Association. Adherence to therapy is a particular concern in this population, and the association between poor adherence and worsening glycemic control indicates that there is a critical need to improve adherence...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0621-6

    authors: Datye KA,Moore DJ,Russell WE,Jaser SS

    更新日期:2015-08-01 00:00:00

  • The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes.

    abstract:PURPOSE OF REVIEW:To evaluate the treatment of type 2 diabetes from a cardiologist's view. RECENT FINDINGS:A new era in the treatment of type 2 diabetes began for the cardiologist in 2015 with the publication of the EMPA-REG outcome trial finding a significant reduction in CV death with empagliflozin (oral sodium-gluc...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1114-1

    authors: Chilton RJ,Gallegos KM,Silva-Cardoso J,Oliveros R,Pham S

    更新日期:2018-11-08 00:00:00

  • Clues from bariatric surgery: reversing insulin resistance to heal the heart.

    abstract::Obesity is a state of metabolic dysregulation of the whole organism and a major contributing factor to the epidemic of insulin resistant diabetes. The nonpharmacologic treatment of obesity with bariatric surgery results in a dramatic and almost instantaneous reversal of insulin resistance. The present review collectiv...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-013-0364-1

    authors: Khalaf KI,Taegtmeyer H

    更新日期:2013-04-01 00:00:00

  • Central nervous system and control of endogenous glucose production.

    abstract::Recent evidence points to the crucial role of the central nervous system in controlling glucose homeostasis. Hypothalamic centers involved in the regulation of energy balance and endogenous glucose production constantly sense fuel availability by receiving and integrating inputs from circulating nutrients and hormones...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-006-0033-8

    authors: Demuro G,Obici S

    更新日期:2006-06-01 00:00:00

  • Lipodystrophic diabetes mellitus: a lesson for other forms of diabetes?

    abstract::Lipodystrophies are a genetically heterogeneous group of disorders characterized by loss of subcutaneous adipose tissue and metabolic dysfunction, including insulin resistance, increased levels of free fatty acids, abnormal adipocytokine secretion, and ectopic fat deposition, which are also observed in patients with v...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0578-5

    authors: Ficarella R,Laviola L,Giorgino F

    更新日期:2015-03-01 00:00:00

  • What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

    abstract:PURPOSE OF REVIEW:We highlight the unique properties of the sodium-glucose cotransporter-2 (SGLT-2 inhibitors) which may lend favorably to their efficient integration in the background of other heart failure (HF) therapies. We also discuss the unique aspects of SGLT-2 inhibitor dosing, lack of titration needs, effects ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01347-3

    authors: Khan MS,Vaduganathan M

    更新日期:2020-10-11 00:00:00

  • Dyslipidemia in type 2 diabetes mellitus.

    abstract::Cardiovascular disease is a significant cause of morbidity and mortality in patients with diabetes mellitus (DM). DM is now recognized as a risk equivalent for coronary heart disease. The lipid profile in patients with type 2 DM is characterized by elevated triglycerides, low levels of high-density lipoprotein cholest...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0036-0

    authors: Gadi R,Samaha FF

    更新日期:2007-06-01 00:00:00

  • The H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy.

    abstract:PURPOSE OF REVIEW:Neuropathic pain may arise from multiple mechanisms and locations. Efficacy of current treatments for painful diabetic neuropathy is limited to an unpredictable subset of patients, possibly reflecting diversity of pain generator mechanisms, and there is a lack of targeted treatments for individual pat...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-0969-5

    authors: Lee-Kubli C,Marshall AG,Malik RA,Calcutt NA

    更新日期:2018-01-23 00:00:00

  • Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad.

    abstract:PURPOSE OF REVIEW:The micro/macrovascular complications of diabetes cause considerable morbidity and premature mortality. The SGLT2 inhibitors are the first diabetes medications with significant benefits on microvascular disease (nephropathy) and macrovascular cardiovascular disease. In this review, we evaluate one of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01359-z

    authors: Ekanayake P,Hupfeld C,Mudaliar S

    更新日期:2020-11-23 00:00:00